AG0012YZ

137234-62-9 | 4-Pyrimidineethanol, α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-, (αR,βS)-

Chemical structure of 4-Pyrimidineethanol, α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-, (αR,βS)-, CAS 137234-62-9
AG0012YZ
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 137234-62-9
Catalog Number AG0012YZ(AGN-PC-0PLCMZ)
Chemical Name 4-Pyrimidineethanol, α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-, (αR,βS)-
IUPAC Name (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
InChI InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1
InChI Key BCEHBSKCWLPMDN-MGPLVRAMSA-N
MDL Number MFCD00905717
Molecular Formula C16H14F3N5O
Molecular Weight 349.3105
NSC Number 759888
SMILES FC1=C(C=CC(=C1)F)[C@@](CN1N=CN=C1)([C@@H](C)C1=NC=NC=C1F)O
UNII JFU09I87TR
Synonyms
UK 109,496, UK 109496, UK-109,496, UK-109496, UK109,496, UK109496, Vfend, voriconazole, Voriconazole, 137234-62-9, Vfend, UK-109496, (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, Voriconazol, UK 109496, Voriconazolum, Voriconazole [USAN:INN:BAN], UNII-JFU09I87TR, DRG-0301, UK-109,496, (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol, VCZ, CHEMBL638, JFU09I87TR, CPD000466350, C16H14F3N5O, CHEBI:10023, (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, VRC, DSSTox_CID_26485, DSSTox_RID_81656, DSSTox_GSID_46485, 2R,3S-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-, 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))-, Vorikonazole, (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-((1H)-1,2,4-triazol-1-yl)-butan-2-ol, SMR000466350, CAS-137234-62-9, Vfend (TN), Voriconazole related compound A, VFEND I.V., Pfizer, MFCD00905717, NCGC00164622-01, Voriconazole, 98%, Voriconazole - Vfend, (+/-)-Voriconazole, Voriconazole in combination with MGCD290, AC1L2GHR, Voriconazole, (+/-)-, AC1Q4O6I, SCHEMBL36233, MLS000759464, MLS001424082, MLS006010028, DTXSID5046485, CTK8E9205, ZINC14864, SYN3012, Voriconazole (JP17/USAN/INN), Voriconazole, >=98% (HPLC), BCEHBSKCWLPMDN-MGPLVRAMSA-N, BCPP000019, HMS2051N09, HMS3260M22, HMS3713F12, Pharmakon1600-01502346, Tox21_112241, Tox21_500150, Voriconazole 2.0 mg/ml in Methanol, AC-823, BDBM50333117, MFCD20488064, NSC759888, s1442, AKOS005145705, Tox21_112241_1, CCG-100941, CS-1227, DB00582, KS-1157, NC00191, NSC-759888, SB17419, KS-0000001W, NCGC00164622-02, NCGC00164622-04, NCGC00260835-01, (alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, AN-15471, BC660191, HY-76200, I992, SAM001246664, SC-25806, Voriconazole related compound A RS [USP], AB0013963, LS-181799, RT-016239, TL8000858, FT-0082604, FT-0631154, SW197571-2, C07622, D00578, J10329, W-5208, AB00639948-04, AB00639948-06, AB00639948_07, AB00639948_08, Voriconazole, VETRANAL(TM), analytical standard, 234V629, J-006986, Z2616414875, UNII-USG4B1CD29 component BCEHBSKCWLPMDN-MGPLVRAMSA-N, Voriconazole, European Pharmacopoeia (EP) Reference Standard, Voriconazole, United States Pharmacopeia (USP) Reference Standard, (2R,3S)-2,3-bis(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, Voriconazole, Pharmaceutical Secondary Standard: Certified Reference Material, (2R,3S)-2-(2,4-Difluoro-phenyl)-3-(5-fluoro-pyrimidin-4-yl)-1-[1,2,4]triazol-1-yl-butan-2-ol, (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl) butan-2-ol, (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol, (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol, 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (alphaR,betaS)-rel-, V-fend, Vfend, Voriconazole, Pfizer brand of voriconazole, D0N3VR, UNII-USG4B1CD29, USG4B1CD29, Voriconazole (JAN/USAN/INN), Voriconazole [USAN:BAN:INN], CID71616, C16-H14-F3-N5-O, UK109496, ACN-036096, CB11360, CS-O-02561, UK 109,496, UK109,496, A4320, V0116, A10978, C102790, D065819, 188416-29-7, VOR, Voriconazole, 98%, a potent and broad-spectrum anti-fungal agent - 1G 1g, (2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (alpha R,beta S)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimideethanol, 136285-65-9, 173967-54-9,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited